Invention Grant
- Patent Title: Use of tryptanthrin compounds for immune potentiation
- Patent Title (中): 使用色胺康化合物进行免疫增强
-
Application No.: US10762873Application Date: 2004-01-21
-
Publication No.: US08193185B2Publication Date: 2012-06-05
- Inventor: Nicholas M. Valiante
- Applicant: Nicholas M. Valiante
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Helen Lee; Otis Littlefield
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/54 ; A61K31/50 ; C07D239/42 ; C07D401/04 ; C07D471/22 ; C07D487/04 ; C07D471/04
Abstract:
The invention provides immunostimulatory compositions and methods of administration thereof. Also provided are methods of administering a tryptanthrin compound in an effective amount to enhance the immune response of a subject to an antigen. Also provided are methods of administering an effective amount of a tryptanthrin to stimulate the immune response in a subject for the treatment of cancer. Further provided are methods of administering a tryptanthrin compounds as an immunotherapeutic in the treatment of infectious diseases.
Public/Granted literature
- US20040241192A1 Use of tryptanthrin compounds for immune potentiation Public/Granted day:2004-12-02
Information query
IPC分类:
